Financials ICL Group Ltd

Equities

ICL

IL0002810146

Agricultural Chemicals

Market Closed - TEL AVIV STOCK EXCHANGE 10:24:10 2024-06-10 am EDT 5-day change 1st Jan Change
1,713 ILa -0.81% Intraday chart for ICL Group Ltd -0.29% -5.78%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 6,031 6,519 12,439 9,330 6,489 5,900 - -
Enterprise Value (EV) 1 8,441 8,982 14,888 11,413 8,584 7,715 7,577 7,354
P/E ratio 12.7 x 509 x 16.1 x 4.34 x 10.1 x 12.8 x 10.2 x 10.5 x
Yield 4.67% 1.97% 3.21% 12.6% 5.36% 3.71% 4.91% 4.78%
Capitalization / Revenue 1.14 x 1.29 x 1.79 x 0.93 x 0.86 x 0.85 x 0.8 x 0.79 x
EV / Revenue 1.6 x 1.78 x 2.14 x 1.14 x 1.14 x 1.11 x 1.02 x 0.98 x
EV / EBITDA 7.05 x 9.07 x 9.07 x 2.85 x 4.89 x 5.57 x 4.77 x 4.49 x
EV / FCF 18.1 x 40.6 x 32.8 x 8.68 x 10.5 x 21.4 x 19.2 x 17.1 x
FCF Yield 5.53% 2.46% 3.05% 11.5% 9.49% 4.68% 5.21% 5.83%
Price to Book 1.54 x 1.66 x 2.75 x 1.71 x 1.13 x 0.98 x 0.94 x 0.9 x
Nbr of stocks (in thousands) 1,280,351 1,280,551 1,287,151 1,287,151 1,289,256 1,289,933 - -
Reference price 2 4.710 5.091 9.664 7.248 5.033 4.574 4.574 4.574
Announcement Date 2/13/20 2/11/21 2/9/22 2/15/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,271 5,043 6,955 10,015 7,536 6,964 7,404 7,473
EBITDA 1 1,198 990 1,642 4,007 1,754 1,386 1,589 1,640
EBIT 1 760 509 1,194 3,509 1,218 826.1 1,017 1,116
Operating Margin 14.42% 10.09% 17.17% 35.04% 16.16% 11.86% 13.74% 14.93%
Earnings before Tax (EBT) 1 628 49 1,092 3,404 974 653.8 841.6 805.2
Net income 1 475 11 783 2,159 647 460.8 579.2 563.6
Net margin 9.01% 0.22% 11.26% 21.56% 8.59% 6.62% 7.82% 7.54%
EPS 2 0.3700 0.0100 0.6000 1.670 0.5000 0.3570 0.4487 0.4368
Free Cash Flow 1 467 221 454 1,315 815 361 395 429
FCF margin 8.86% 4.38% 6.53% 13.13% 10.81% 5.18% 5.33% 5.74%
FCF Conversion (EBITDA) 38.98% 22.32% 27.65% 32.82% 46.47% 26.05% 24.86% 26.16%
FCF Conversion (Net income) 98.32% 2,009.09% 57.98% 60.91% 125.97% 78.35% 68.2% 76.11%
Dividend per Share 2 0.2200 0.1005 0.3100 0.9100 0.2700 0.1698 0.2244 0.2184
Announcement Date 2/13/20 2/11/21 2/9/22 2/15/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 2,038 2,525 2,880 2,519 2,091 - - - 1,690 1,735 1,766 2,001 1,915 - -
EBITDA 1 575 1,002 1,258 1,049 698 610 - 346 357 362 336.9 355.9 355.5 - -
EBIT 1 458 - 1,139 928 562 - - - 211 203 197.7 206.9 198.1 - -
Operating Margin 22.47% - 39.55% 36.84% 26.88% - - - 12.49% 11.7% 11.2% 10.34% 10.34% - -
Earnings before Tax (EBT) 1 - - - - - - - - 117 168 224.1 241.1 - - -
Net income 1 283 - 563 633 331 280 163 137 67 109 97.9 109.1 140.3 - -
Net margin 13.89% - 19.55% 25.13% 15.83% - - - 3.96% 6.28% 5.54% 5.45% 7.33% - -
EPS 2 0.2100 - 0.4400 0.4900 0.2500 0.2200 0.1300 0.1100 0.0500 0.0800 0.0759 0.0845 0.1087 - -
Dividend per Share 2 0.1300 0.2400 0.2918 0.2435 0.1400 - - - 0.0500 0.0500 0.0421 0.0428 0.0461 - -
Announcement Date 2/9/22 5/11/22 7/27/22 11/9/22 2/15/23 5/10/23 8/9/23 11/8/23 2/28/24 5/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,410 2,463 2,449 2,083 2,095 1,815 1,677 1,455
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.012 x 2.488 x 1.491 x 0.5198 x 1.194 x 1.31 x 1.056 x 0.8872 x
Free Cash Flow 1 467 221 454 1,315 815 361 395 429
ROE (net income / shareholders' equity) 12.4% 6.57% 18.5% 43.2% 11.5% 7.64% 10.3% 10.1%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 3.070 3.070 3.520 4.240 4.470 4.640 4.850 5.070
Cash Flow per Share 2 0.7700 0.6300 0.8300 1.570 1.240 0.8700 0.8300 -
Capex 1 576 626 611 747 780 815 750 750
Capex / Sales 10.93% 12.41% 8.79% 7.46% 10.35% 11.7% 10.13% 10.04%
Announcement Date 2/13/20 2/11/21 2/9/22 2/15/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
4.574 USD
Average target price
5.503 USD
Spread / Average Target
+20.33%
Consensus
  1. Stock Market
  2. Equities
  3. ICL Stock
  4. Financials ICL Group Ltd